Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like FDA Hails Novartis' Kisqali a Breakthrough January 2, 2018 Puma Biotech Surges After the FDA Officially Approves Breast Cancer Drug July 17, 2017 Top 9 Biotech Giants to Work for in New Jersey July 5, 2017
